Study to evaluate the the safety and efficacy of oxycodone/naloxone in patients with parkinson's disease

Trial Profile

Study to evaluate the the safety and efficacy of oxycodone/naloxone in patients with parkinson's disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2015

At a glance

  • Drugs Oxycodone/naloxone (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Aug 2015 New trial record
    • 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top